Cezary Swider - Concepedia

Concepedia

Author

Cezary Swider

University of Pennsylvania

Also Known As

C R Swider, C SWIDER, C Swider, C. SWIDER, C. Swider, C. Świder, C.R. Swider, Cezary R Swider, Cezary R. Swider, Cezary Swider

37

Publications

1.4K

Citations

11

H-Index

38

Concepts

All Affiliations

University of Pennsylvania Research Center Borstel - Leibniz Lung Center Children's Hospital of Philadelphia Ludwik Hirszfeld Institute of Immunology and Experimental Therapy

CS

About

Cezary Swider is an author at University of Pennsylvania specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	905
2	Cell Biology	3	3	677
3	Immunology	3	3	608
4	Health Sciences	1	1	380
5	Public Health	1	1	84

Cezary Swider

×

13

Publications

1.4K

Citations

11

H-Index

	Year	Citations
Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice Jean‐Emmanuel Sarry, Kathleen M. Murphy, Robin Perry, Journal of Clinical Investigation Mixed-phenotype Acute LeukemiaImmunologyStem Cell BiologyTumor BiologyMyeloid Neoplasia	2010	380
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders Elizabeth O. Hexner, Cynthia Serdikoff, Mahfuza Jan, Blood	2007	251
Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1α-induced metabolic reprograming Fanyu Zhao, Anthony Mancuso, Thi Bui, Oncogene Imatinib ResistanceBcr-abl UpregulationSystems BiologyHif-1α-induced MetabolicCell Regulation	2010	175
TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSIS Ulrike Seitzer, Cezary Swider, Frank Stüber, Cytokine Autoimmune DiseaseDisease MechanismPathogenesisImmunologyPathology	1997	144
A robust xenotransplantation model for acute myeloid leukemia P V Sanchez, Robin Perry, Jean‐Emmanuel Sarry, Leukemia Hematological MalignancyXenotransplantationRobust Xenotransplantation ModelMedicineMixed-phenotype Acute Leukemia	2009	122
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia Alexander E. Perl, Margaret Kasner, Donald E. Tsai, Clinical Cancer Research	2009	102
TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Cezary Swider, Leonhard Schnittger, Katarzyna Bogunia‐Kubik, PubMed Inflammatory Lung DiseaseSarcoidosis PatientsAdvanced Lung DiseaseHla-dr GenotypingDisease Etiology	1999	84
Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias Susan E. Shetzline, Ravikumar Rallapalli, Kelley J. Dowd, Blood	2004	52
A Phase I Study of Bexarotene, a Retinoic X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia Donald E. Tsai, Selina M. Luger, Charalambos Andreadis, Clinical Cancer Research	2008	34
CEP-701 Is a JAK2 Inhibitor Which Attenuates JAK2/STAT5 Signaling Pathway and the Proliferation of Primary Cells from Patients with Myeloproliferative Disorders. Paweł Dobrzański, Elizabeth O. Hexner, Cynthia Serdikoff, Blood	2006	20

Page 1